KYMAB
Live / Registered — Registered (as of 07 Sept 2021)
What this means for you
Registered since 07 Sept 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88441516
- Registration number
- 6473731
- Mark type
- Stylized text
- Filed
- 22 May 2019
- Published for opposition
- 23 Mar 2021
- Registered
- 07 Sept 2021
- Attorney of record
- Mark H. Tidman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations containing monoclonal antibodies for the treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; Veterinary preparations containing monoclonal antibodies for treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, autoimmune and infectious diseases, and medical diagnostics; sanitary preparations containing monoclonal antibodies for medical purposes; dietetic food and beverages containing monoclonal antibodies, for medical and veterinary use; dietary supplements containing monoclonal antibodies for human beings and animals; dietary supplements containing monoclonal antibodies; Pharmaceutical preparations containing monoclonal antibodies for the treatment of treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases and in the field of antibodies and immuno-oncology
- Class 042 — Scientific and technological services: Scientific, medical and technological services, namely, scientific research, analysis and testing in the field of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology, and scientific research, analysis and testing in the field of antibodies and cell repertoires and research, development and design in the field of science, medicine, and technology; industrial analysis and industrial research services, namely, testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; design and development of computer hardware and software; design and development of hardware and software for analysis and testing in the field of antibodies and biological cells and genetic discovery and clinical development; Clinical research in the field of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; Conducting clinical trials for others in the field of antibodies, and medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; conducting clinical trials for pharmaceutical products for others in the field of medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; scientific and medical screening and assaying of medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; scientific and medical screening and assaying in the field of genetic discovery, clinical development, antibodies and biological cells; chemical analysis; chemical research
- Class 044 — Medical, beauty and agricultural services: Medical services; diagnostic and prognostic medical services; veterinary services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; pharmaceutical consultation in the nature of pharmacy advice; medical and health services in the nature of the treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics; Medical screening
Owner
- Kymab Limited, Cambridge, GB
- Kymab Limited, Cambridge, GB
- Kymab Limited, Cambridge, GB
Prosecution history
- 07 Sept 2021 — REGISTERED-PRINCIPAL REGISTER
- 01 Aug 2021 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 21 Apr 2021 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 23 Mar 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Mar 2021 — PUBLISHED FOR OPPOSITION
- 03 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Feb 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Feb 2021 — EXAMINER'S AMENDMENT ENTERED
- 17 Feb 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 17 Feb 2021 — EXAMINERS AMENDMENT E-MAILED
- 17 Feb 2021 — EXAMINERS AMENDMENT -WRITTEN
- 09 Oct 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Oct 2020 — NON-FINAL ACTION E-MAILED
- 09 Oct 2020 — NON-FINAL ACTION WRITTEN
- 22 Aug 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED